Physician profile
William Shaw
NPI 1730149550
$808.96
in general payments reported to CMS, 2019-2025
14 companies · $44.39 in 2025
The $44.39 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $72.97 · 2021: $257 · 2022: $187 · 2023: $24.49 · 2024: $120 · 2025: $44.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $189.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $136.91 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $130.99 | 2020-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $125.83 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $100.92 | 2024 | Eylea Hd |
| Abbvie INC. | $52.45 | 2022-2023 | Durysta |
| Kala Pharmaceuticals, INC. | $46.83 | 2021 | |
| Apellis Pharmaceuticals, INC. | $44.39 | 2025 | Syfovre |
| Akorn Operating Company LLC | $35.99 | 2021 | |
| Allergan, INC. | $31.40 | 2021-2022 | |
| Thea Pharma INC. | $24.04 | 2022 | |
| Horizon Therapeutics Plc | $23.24 | 2020 | |
| Bausch & Lomb Americas INC. | $21.73 | 2022 | |
| Mallinckrodt Hospital Products INC. | $19.49 | 2024 | Acthar |
| Novartis Pharmaceuticals Corporation | $14.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.